scholarly article | Q13442814 |
P50 | author | Matthias Diem | Q64034479 |
Shuo Yang | Q90415887 | ||
Jakob D H Liu | Q90415889 | ||
Chris Oostenbrink | Q30505204 | ||
P2093 | author name string | Jacques Vervoort | |
Ivonne M C M Rietjens | |||
Sebastiaan Wesseling | |||
P2860 | cites work | Urinary Methyleugenol-deoxyadenosine Adduct as a Potential Biomarker of Methyleugenol Exposure in Rats. | Q48253644 |
Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes. | Q48608922 | ||
Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole. | Q53544686 | ||
An improved nucleic acid parameter set for the GROMOS force field | Q56225273 | ||
Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole | Q61774412 | ||
The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes | Q70908767 | ||
Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver | Q72228908 | ||
Folding-unfolding thermodynamics of a beta-heptapeptide from equilibrium simulations | Q74452346 | ||
DNA quality control by conformational readout on the undamaged strand of the double helix | Q81122380 | ||
Nucleotide excision repair in eukaryotes | Q26850656 | ||
Recognition of Damaged DNA for Nucleotide Excision Repair: A Correlated Motion Mechanism with a Mismatched cis-syn Thymine Dimer Lesion | Q27301752 | ||
Recognition of DNA damage by the Rad4 nucleotide excision repair protein | Q27648368 | ||
3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures | Q27860547 | ||
A fast pairlist-construction algorithm for molecular simulations under periodic boundary conditions | Q28269160 | ||
Nucleotide excision repair efficiencies of bulky carcinogen-DNA adducts are governed by a balance between stabilizing and destabilizing interactions | Q28731587 | ||
The human DNA repair factor XPC-HR23B distinguishes stereoisomeric benzo[a]pyrenyl-DNA lesions | Q28757533 | ||
Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up | Q31420859 | ||
Characterization and analysis of Chinese hamster ovary cell ERCC1 mutant alleles | Q32033728 | ||
A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes | Q33530423 | ||
Nucleotide Excision Repair Lesion-Recognition Protein Rad4 Captures a Pre-Flipped Partner Base in a Benzo[a]pyrene-Derived DNA Lesion: How Structure Impacts the Binding Pathway | Q33820131 | ||
Base sequence context effects on nucleotide excision repair | Q34143686 | ||
Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole | Q34686516 | ||
Dihedral-based segment identification and classification of biopolymers II: polynucleotides | Q35074442 | ||
Resistance of bulky DNA lesions to nucleotide excision repair can result from extensive aromatic lesion-base stacking interactions | Q35468354 | ||
Resistance to Nucleotide Excision Repair of Bulky Guanine Adducts Opposite Abasic Sites in DNA Duplexes and Relationships between Structure and Function | Q35764540 | ||
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins | Q35828228 | ||
Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes | Q36573952 | ||
The sequence dependence of human nucleotide excision repair efficiencies of benzo[a]pyrene-derived DNA lesions: insights into the structural factors that favor dual incisions | Q37281223 | ||
Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications | Q37579509 | ||
Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. | Q39988841 | ||
Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies | Q39995517 | ||
Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells | Q40105953 | ||
GROMOS++ Software for the Analysis of Biomolecular Simulation Trajectories | Q40284674 | ||
Repair-Resistant DNA Lesions | Q41508281 | ||
Sequence context- and temperature-dependent nucleotide excision repair of a benzo[a]pyrene diol epoxide-guanine DNA adduct catalyzed by thermophilic UvrABC proteins. | Q43022682 | ||
Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples | Q44604444 | ||
Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling. | Q46565082 | ||
Impact of structural and metabolic variations on the toxicity and carcinogenicity of hydroxy- and alkoxy-substituted allyl- and propenylbenzenes. | Q46890644 | ||
Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation. | Q48160611 | ||
P577 | publication date | 2020-03-18 | |
P1433 | published in | Archives of Toxicology | Q635837 |
P1476 | title | Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix |
Search more.